Care To Live is very saddened by the loss of member Stephen H. Study. It is over a year since Provenge was voted 17-0 safe and 13-4 substantial evidence of efficacy by an FDA panel of experts. We are continuing our efforts on behalf of our have many prostate cancer sufferers desperately awaiting the approval of Provenge before it is too late for them. Here is week #4 of our ad campaign. Come on FDA. APPROVE PROVENGE NOW!!!!

Week #4 Color Ad Read and Print caretoliverockvillegazette4ad-part-2web.pdf

Week #4 Black & White Ad Read and Print caretoliverockvillegazette4ad-part-2bw.pdf

Next week, Week #5, we will place our ad in the Chevy Chase/Bethesda Gazette as we continue to raise awareness throughout the Maryland area as to the debacle that took place at the FDA in Rockville.

Popularity: 34%

Tags: Brachytherapy, Cancer Vaccine, Care To Live, CareToLive, commissioner Andrew Von Eschenbach, Dendreon, FDA, foia, Freedom of Information Act, Howard Scher, Immunotherapy, maha hussain, Michael Milken, Prostate Cancer, Prostate Gland, Prostatectomy, provenge, Richard Pazdur, Robotic Surgery, Thomas R Fleming

This entry was posted on Tuesday, April 22nd, 2008 at 9:11 pm and is filed under The Cause, The Dysfunctional FDA. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.